Inventor

RAEYMAEKERS ALFONS H M

BE40 patents

⚠️ This page may combine multiple inventors who share the name “RAEYMAEKERS ALFONS H M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RAEYMAEKERS ALFONS H M

JANSSEN PHARMACEUTICA NV

1,3-Dihydro-2H-imidazo[4,5-B]quinolin-2-one derivatives

(1H-azol-1-ylmethyl) substituted quinazoline derivatives

(1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders

Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives

(1h-azol-1-ylmethyl) substituted quinoxaline derivatives

(1H-azol-1-ylmethyl)substituted quinoxaline derivatives

Method of treating epithelial disorders

Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor

(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them

5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives

1,3-dihydro-2H-imidazo-[4,5-β]quinolin-2-one derivatives and intermediates

Method of treating epithelial disorders

Benzimidazoles useful in treating epithelial disorders

Anti-protozoal 5,6-dihydro-2-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-dione derivatives, compositions, and method of use therefor

Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives, compositions and use

Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates

(1H-azol-1-ylmethyl)substituted quinoline derivatives

Intermediates for the preparation of 1,3,dihydro-2H-imidazo[4,5-B]quinolin-2-one derivatives

Method of treating epithelial disorders

Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones

5,6-dihydro-2-(substituted phenyl)-1,2,4-triazine-3,5(2H,4H)-diones

5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives

(1h-benzimidazol-2-yl)carbamates

Glycine derivatives

Positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives

Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives

[5(6)-(benzisoxa-,benzisothia-or indazol-3-yl)-1H-benzimidazol-2-yl]carbamates

Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2-(thi)ones

6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles

α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitriles

Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives

Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones

(1h-azol-1-ylmethyl) substituted quinoline derivatives

(3-pyridinyl)methanone oxime derivatives

[[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Positive inotropic and lusitropic pyrroloquinolinone derivatives

Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-beta]thiazole derivatives

HANSSEN PHARMACEUTICA

(1H-azol-1-ylmethyl)substituted quinoline derivatives

JANSSEN PHARMACEUTICA N V FRAM

5,6-Dihydro-2-(substituted phenyl)-1,2,4-triazine-3,5,(2H,4H)-diones and their use as protozoa combating agents